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ABSTRACT
Objectives: This study examined how environmental,
health, social, behavioural and genetic factors interact
to contribute to myocardial infarction (MI) risk.
Design: Survey data collected by Wisconsin
Longitudinal Study (WLS), USA, from 1957 to 2011,
including 235 environmental, health, social and
behavioural factors, and 77 single-
nucleotide polymorphisms were analysed for
association with MI. To identify associations with MI
we utilized recursive partitioning and random forest
prior to logistic regression and chi-squared analyses.
Participants: 6198 WLS participants (2938 men;
3260 women) who (1) had a MI before 72 years and
(2) had a MI between 65 and 72 years.
Results: In men, stroke (LR OR: 5.01, 95% CI 3.36 to
7.48), high cholesterol (3.29, 2.59 to 4.18), diabetes
(3.24, 2.53 to 4.15) and high blood pressure (2.39,
1.92 to 2.96) were significantly associated with MI up
to 72 years of age. For those with high cholesterol, the
interaction of smoking and lower alcohol consumption
increased prevalence from 23% to 41%, with exposure
to dangerous working conditions, a factor not
previously linked with MI, further increasing prevalence
to 50%. Conversely, MI was reported in <2.5% of men
with normal cholesterol and no history of diabetes or
depression. Only stroke (4.08, 2.17 to 7.65) and
diabetes (2.71, 1.81 to 4.04) by 65 remained
significantly associated with MI for men after age 65.
For women, diabetes (5.62, 4.08 to 7.75), high blood
pressure (3.21, 2.34 to 4.39), high cholesterol (2.03,
1.38 to 3.00) and dissatisfaction with their financial
situation (4.00, 1.94 to 8.27) were significantly
associated with MI up to 72 years of age. Conversely,
often engaging in physical activity alone (0.53, 0.32 to
0.89) or with others (0.34, 0.21 to 0.57) was
associated with the largest reduction in odds of MI.
Being non-diabetic with normal blood pressure and
engaging in physical activity often lowered prevalence
of MI to 0.2%. Only diabetes by 65 (4.25, 2.50 to
7.24) and being exposed to dangerous work conditions
at 54 (2.24, 1.36 to 3.69) remained significantly
associated with MI for women after age 65, while still
menstruating at 54 (0.46, 0.23 to 0.91) was associated
with reduced odds of MI.
Conclusions: Together these results indicate
important differences in factors associated with MI
between the sexes, that combinations of factors greatly
influence the likelihood of MI, that MI-associated
factors change and associations weaken after 65 years
of age in both sexes, and that the limited genotypes
assessed were secondary to environmental, health,
social and behavioral factors.
INTRODUCTION
Heart disease impacts ∼26.6 million US
adults and is the leading cause of death
among men and women in the USA,
accounting for 25% of deaths (∼600 000
people) annually.1 2 An estimated 935 000
people in the USA suffer from a myocardial
infarction (MI) every year.3
MI is a symptom of advanced or severe heart
disease,4–6 and the major modifiable risk
factors for MI include high blood pressure,3 7 8
high blood cholesterol,9–13 diabetes (melli-
tus),14–16 smoking/tobacco use,17–21 obesity
and being overweight,22–27 poor nutrition/
diet,28–36 physical inactivity37–41 and (no or
excessive) alcohol use.42–47 Stress has also been
shown to be an important (modifiable) risk
Strengths and limitations of this study
▪ 54-year-long longitudinal survey study
(Wisconsin Longitudinal Study, WLS).
▪ Large number of participants with high response
rates.
▪ Large breadth of factors, including environmen-
tal, health, social, behavioural and genetic.
▪ Genetic data used in this study were limited due
to prior selection of single-nucleotide poly-
morphisms by WLS.
▪ WLS participants are almost exclusively middle-
class to upper-middle-class, non-Hispanic whites
from Wisconsin, therefore social-factor homoge-
neities reduce generalisability.
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factor for MI.48–51 The major non-modifiable risk factors
for MI include sex,52–57 age,3 58 59 family history60–63 and
race.1 3 64 However, not all individuals with these risk factors
experience a MI. Thus, it is likely that combinations of
these risk factors, or as yet unknown risk factors, are import-
ant in the aetiology of the disease.
Other non-modifiable risk factors include genetic
polymorphisms such as those identified in APOE (apoli-
poprotein E)65 66 CETP (cholesteryl ester transfer
protein)67–69 and CDKN2A/2B (cyclin-dependent kinase
2A/2B),70 but there is no consensus about which gene
(s) are most predictive of MI. In addition, there are few
large-scale studies that have looked at the interactions
between genetic and environmental, health, social and
behavioural factors that predict MI.
Research has shown that risk factors for heart disease and
MI are moderated by sex and age, and the interaction of
risk factors with heart disease and MI affects men and
women differently at different ages throughout their
lives.53–55 57 71 For example, women are more likely than
men to die within 1 year of experiencing an MI when
younger,72 73 but in general first experience MI later in life
than do men,55 although men are more likely to experi-
ence MI overall.3 Identification of sex-specific factors asso-
ciated with MI and how those associations change over time
is important for predicting disease risk throughout life.
In this study, we examined how the interaction among
environmental, health, social, behavioural and genetic
factors associates with MI, with the goal of determining
(1) differences in factors associated with MI between
men and women, with a focus on the interaction among
factors; (2) how interactions among these factors affect
MI occurrence; (3) how factors associated with MI
change over a person’s lifetime, again with a focus on
the interaction among factors and (4) what combined
factors are associated with reduced occurrence of MI,
even in the presence of other known risk factors.
METHODS
Study participants and WLS survey data
The Wisconsin Longitudinal Study (WLS) is a 54-year-long
survey study on the lives of a cohort of 1957 Wisconsin
high-school graduates. The original cohort of participants
was made up of 10 317 men and women, randomly
selected from those graduating from a Wisconsin high
school in 1957. Self-reported survey data were collected
from WLS graduate participants in 1957, 1964, 1975, 1993,
2004 and 2011. Data from each of the aforementioned
survey rounds were included in this study, with many of
the selected variables representing the same questions
asked at multiple time points (WLS survey rounds). In
addition, DNA saliva samples were provided by a subset of
the WLS (4562 graduates) and 77 single-nucleotide poly-
morphisms (SNPs) were genotyped for each of these parti-
cipants in 2009, providing genetic data for a subset of the
WLS as well. Additional information about the WLS survey
data and participants can be found elsewhere74 75 (http://
www.ssc.wisc.edu/wlsresearch/).
The WLS has enjoyed high response rates across mul-
tiple survey waves. The data for the current analyses
come primarily from the 1993, 2004, and 2011 survey
waves when the cohort was 53, 64 and 71 years old,
respectively. In 1993, 8493 cohort members participated
in the telephone survey, 588 refused to participate, 587
were deceased and 649 were unfielded for either admin-
istrative reasons or permanent disability. In 2004, 7265
cohort members participated in the telephone survey,
956 refused, 1287 were deceased and 809 were
unfielded. Finally, for the 2011 in-home interview, 5968
cohort members participated in the survey, 1088
refused, 1587 were deceased and 1674 were unfielded
(see online supplementary table S1). Among those not
deceased, response rates for these survey waves were
87%, 80% and 60%, respectively. Also excluding
unfielded cases from the denominator brings the
response rates to 94%, 88% and 85%.
Study questions and dependent variables
This study examined factors potentially associated with
MI using environmental, health, social, behavioural and
genetic data available through the WLS. Two sets of data
were analysed based on survey years of data collection,
looking at anyone who reported a MI up to 72 years of
age and only those who reported a MI between 65 and
72 years. We did this for two reasons: (1) to examine MI
up to 72 years and what factors would be associated with
this group regardless of when their MI occurred; and
(2) an analysis of factors that occurred only before a MI.
Owing to the timing of the survey years, this allowed us
to look at factors associated with MI at any point in
one’s lifetime (up to 72 years), versus factors associated
with a MI in ‘older age’ (65–72 years).
In order to create our two dependent variables, we
compiled data from the 2004 and 2011 WLS surveys
including National Death Index (NDI) data. The first
dependent variable, ‘MI by 72 years of age’, was coded
as ‘yes’ if a participant reported experiencing a MI in
2004 or 2011 or died of MI according to the NDI (ICD-9
or ICD-10 codes; note: NDI data were collected by the
WLS only up to 2006 at the time of the current study),
thereby including anyone who reported having a MI to
the WLS. The dependent variable was coded ‘no’ only if
no previous MIs were reported and the participant
reported no MIs in 2011. This resulted in MI data for
6198 graduates, with 776 participants coded as ‘yes’ and
5422 coded as ‘no’ for the given variable. Additionally,
this dependent variable was linked to a data set which
included independent variables from all WLS survey
years, 1957–2011. Characteristics of the WLS participants
included in this study population are shown in table 1.
The second dependent variable, ‘MI between 65 and
72 years of age’, was coded similarly to the first, but
included only those participants who reported no MIs by
2004, thereby excluding individuals who had a MI
before 65 years of age. This dependent variable was
coded as ‘yes’ if the participant reported having a MI
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between 2004 and 2011 (in 2011) or died of acute MI
after 2004 and was coded as ‘no’ if the participant
reported no MIs in 2011. This resulted in MI data for
5321 graduates, with 213 participants coded as ‘yes’ and
5108 coded as ‘no’. This dependent variable was linked
to a data set which included only independent variables
collected during the 2004 survey year or earlier.
Information about specific WLS variables used to create
the two dependent variables for the current study is
provided in online supplementary information 1.
Environmental, health, social and behavioural data
From the data generated by the WLS, official release
V.13.01, we analysed 235 environmental, health, social and
behavioural variables against MI data for WLS participants
included in this study. These included descriptive, family,
spouse, children, personality, medical history, family’s
medical history, general health and weight, exercise, sleep,
smoking, alcohol consumption, social, work-related, socio-
economic, life satisfaction, stress-related and coping, stress-
ful life events, summary psychological and personality
variables collected by the WLS (see online supplementary
table S2). We analysed an additional 26 variables in all
female-specific analyses, which included variables related
to menstruation, menopause, reproductive surgeries and
hormone replacement therapies.
One variable, ‘Summary Score Anger Index, 2004’,
was updated by the WLS during the course of this study,
in July 2014. Therefore, for this variable the updated
version 13.02 data were substituted for the version 13.01
data for all analyses conducted. Additionally, in the WLS
surveys there were some questions that were asked of
only a subset of the WLS participants, specifically, the
alcohol-related and depression-related questions were
only asked of a 79% random subset of the WLS.
SNP genotyping data
Of the 4562 graduates who provided DNA saliva samples
to the WLS, 4012 also answered the MI questions and were
therefore included in the SNP analyses for this study.
A total of 77 SNPs were genotyped for each of these parti-
cipants in 2009, as described in Roetker et al.76 This study
also included five additional genetic variables based on
APOE, because of its known association with cardiovascular
and other disease states.65 77–79 Three APOE alleles: APOE
ɛ2, APOE ɛ3 and APOE ɛ4, determined by the SNPs
rs429358 and rs7412 were used to determine APOE
status.80 81 From this, we created five variables, allele
APOE4±, allele APOE2±, genotype E4/E4, genotype E2/E2
and specific APOE genotype (see online supplementary
table 2).
Statistical analyses
This study looked for independent as well as interactive
effects of environmental, health, social, behavioural and
genetic variables for the 6198 and 5321 WLS graduates
for which data were available for our two dependent
variables (MI by 72 years and MI between 65 and 72),
respectively. Of these, 4012 and 3684 respectively, also
provided genetic data which was analysed for independ-
ent as well as interactive effects separately and in com-
bination with environmental, health, social and
behavioural data, in order to identify the combination
of factors most associated with MI. In order to address
possible collinearity of covariates measured in multiple
survey rounds, we first completed a recursive partition-
ing (RP) and random forest (RF) analysis in order to
reduce the number of variables analysed and then ran
independent logistic regression (LR) analysis for each
independent variable identified, rather than a multiple
regression analysis of all independent variables. A
similar strategy, using machine-learning methodologies
to identify associations followed by LR analysis of individ-
ual factors, has been used in prior studies.76
Recursive partitioning
RP was used to create classification trees to determine
main factor and interactive effects associated with MI
Table 1 Participant characteristics for those included in the current study
Characteristic, survey year collected
Total population:
n (%) or mean (± SD)
Males:
n (%) or mean (± SD)
Females:
n (%) or mean (± SD)
‘MI by 72 years of age’ DV 6198 2938 (47.4%) 3260 (52.6%)
Included in DV ‘MI Between 65 and 72’ 5321 (85.9%) 2404 (81.8%) 2917 (89.5%)
Ever experienced MI 776 (12.5%) 533 (18.1%) 243 (7.5%)***
IQ Score (Henmon-Nelson), 1957 102.1 (14.77) 101.9 (15.22) 102.2 (14.37)
Years of education‡, 1993 13.75 (2.33) 14.14 (2.55) 13.41 (2.05)***
Age at interview, 2004 64.33 (0.70) 64.40 (0.73) 64.27 (0.67)***
Married, 2004 4652 (78.6%) 2368 (85.4%) 2284 (72.7%)***
Total household income, 2004 $30 619 ($7) $42 364 ($6) $22 961 ($8)***
Smoker, 2004 613 (11.6%) 296 (12.0%) 317 (11.2%)
Alcohol (days/month), 2004 7.57 (9.67) 9.47 (10.50) 5.89 (8.54)***
Significant differences between men and women are indicated, and based on Student’s t-test or equal proportions test.
‘***’=p<0.001.
‡Summary of equivalent years of regular education based on highest degree.
DV, dependent variable; MI, myocardial infarction; SD, standard deviation.
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using environmental, health, social, behavioural and
genetic variables, individually and combined, in order to
assess whether MI is better explained by our environ-
ment, our genetics or a combination of both. All RP ana-
lyses were completed using the R program, V.2.15.2 (R:
A language and environment for statistical computing
(program), Vienna, Austria: R Foundation for Statistical
Computing, 2008) with package ‘rpart’ (rpart: Recursive
Partitioning (program), R package version 3.1-55.
version, 2012), based on Breiman’s classification and
regression trees algorithm.82 The usesurrogate param-
eter was set to 0, maxcompete was set to 0, maxsurrogate
was set to 0 and the complexity parameter was set to
0.01. A 10-fold cross-validation procedure was used to
determine how far back to prune the trees. Odds ratios
(ORs) and 95% confidence intervals (CIs) were calcu-
lated using MedCalc (http://www.medcalc.org/calc/
odds_ratio.php; calculations according to Altman83).
When zeros appeared in the terminal nodes of the RP
trees, MedCalc used an ad hoc method to determine
estimates of OR.84 85
Random forest
RF86–89 was used in our association analyses90–93 and was
conducted using the ‘randomForest’ package94 (Online
R documentation for the package ‘randomForest’
(program), 4.6-10 version, 2014) available with the R
program. We chose to use ‘margin measure’ or mean
decrease in accuracy to determine variable import-
ance.95 96 Missing values were imputed for independent
variables using the ‘na.roughfix’ command, which
imputes missing values using either the median value
for numeric variables, or the most frequent level for
factor variables. Using imputed values with the
‘rfImpute’ command for missing data was considered
here, but the bias that was noted in preliminary analyses
was considered too great. Three trials of RF were con-
ducted for each ‘variable importance’ measure, to deter-
mine the replicability of the results, in large part
because of the randomness associated with this particu-
lar test. Using the dependent variable ‘MI by 72 years of
age’ and associated data set, the ‘mtry’ parameter was
set to 34 for men and 36 for women, based on the
lowest out-of-bag (OOB) estimate of error rate of
12.25% and 5.09%, respectively. Using the dependent
variable ‘MI between 65 and 72 years of age’ and asso-
ciated data set, the ‘mtry’ parameter was set to 30 for
men and 32 for women, based on the OOB estimate of
error rate of 5.87% and 2.47%, respectively. The
number of trees in the forest, the ‘ntree’ parameter, was
set to 5000 for men and women in both analyses.
LR and χ2
Single-factor associations with MI were determined for
all environmental, health, social, behavioural and
genetic variables that appeared in either the RP tree(s)
or the RF list(s) of ‘important’ variables generated for
each of the dependent variable analyses, using a LR
model and χ2 test with R. For those cases where the
sample size (one or more categories) was too small for a
χ2 test (n<5), Fisher’s Exact test was used to calculate sig-
nificance. When necessary, Fisher’s Exact test p values
were obtained using Monte Carlo simulation. LR ORs
were determined by exponentiating the coefficients of
the regression models using the R program. All p values
generated from these tests were adjusted for multiple
testing using a q-value adjustment, with the R program
V.2.15.2, package ‘qvalue’97 (qvalue: Q-value estimation
for false discovery rate control (program), R package
version 1.32.0, 2014) which has been shown to be less
stringent than the Bonferroni adjustment. All signifi-
cance findings from LR and χ2 (or Fisher’s Exact test)
reported herein refer to these adjusted values.
Inclusion and Logical Bounding
Only those factors that were identified by at least three of
the four analyses employed and increased or decreased
odds of MI by at least 40% were considered significantly
associated with MI in this study and included herein.
Furthermore, in order to address any bias that may have
been created due to missing data (non-response) in this
study, we performed a ‘logical bounding’ procedure in
which we logically filled in missing data points in our
data set, first with all participants who were not included
due to missing values coded as ‘yes’ for MI and then as
‘no’ for MI. We then reran our LR analyses in order to
see if our ‘overall’ factors associated with MI remained
statistically significant and thereby determine if our
results were robust. All p values generated from this
logical bounding were also adjusted for multiple testing
using q-value adjustment.
RESULTS
To assess changes in MI-associated factors over a
person’s lifetime, separate analyses were performed on
individuals who ever had a MI up to 72 years of age com-
pared to those who had a MI between 65 and 72 years of
age (see the ‘Methods’ section). Participants included in
the ‘MI by 72 years of age’ dependent variable were
47.4% men, had an average IQ of 102.1 with an average
13.75 years of regular education. At the time of the 2004
interview, the average age of participants was 64.3 years,
78.6% were married, with an average total household
income of US$30,619. 11.6% of participants were
smokers, consumed alcohol on average 7.6 days/month,
and 12.5% have ever reported a MI to the WLS (see
table 1). Of these participants, 85.9% were also included
in the ‘MI between 65 and 72 years of age’ dependent
variable. Men in the WLS were significantly more likely
to experience MI than were women, to have more edu-
cation, to be married, to have a higher household
income and to drink alcohol more days per month than
women in the WLS (table 1; based on t-test or equal pro-
portions test). All analyses identified sex as the factor
most associated with MI (see online supplementary
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information 2), therefore men and women were ana-
lysed separately throughout this study. Note to readers:
we reported results in terms of MI ‘by 72’ years and MI
‘between 65 and 72’ years because the majority of parti-
cipants were 65 or younger during the 2004 survey and
72 or younger during the 2011 survey.
Men
MI up to age 72
Interactive effects
RP analysis indicated that 18.1% of men in this study
reported a MI by age 72. High cholesterol by 65 years
old was the most significant factor associated with MI
among men according to RP (figure 1), with a preva-
lence of 23.1% versus 8.4% (OR 3.29, 95% CI 2.59 to
4.18). For men with normal cholesterol at 65, the inter-
actions among factors associated with the largest
increase in MI prevalence were being diabetic by 65,
summary score for openness at 65 and genotype for the
CYP11B2 gene (rs1799998 SNP), increasing MI preva-
lence to 30.6% versus 0.0% (20.22, 1.15 to 355.10). For
men with normal cholesterol who were non-diabetic at
65, important interactions included their summary score
for (psychological) distress/depression at 65 and having
high blood pressure by 65, with MI prevalence at 27.5%
versus 7.5% (4.66, 1.90 to 11.38). Among those men
with a lower summary score for depression, important
interactions included having high cholesterol by 72 and
lower alcohol consumption at 72, with MI prevalence at
26.9% versus 4.4% (6.89, 2.12 to 22.44).
For men who did have high cholesterol by 65, import-
ant interactions among factors associated with MI
include the number of years the participant had smoked
by 54, alcohol consumption at 65, exposure to danger-
ous work conditions at 65 and genotype for the FADS2
gene (rs174575 SNP), with MI prevalence at 46.7%
versus 7.1% (11.38, 1.96 to 66.12). For men who had
high cholesterol by 65, but had smoked fewer years by
54, important interactions included being diabetic by
65, the extent to which one agreed that family worries
or problems distracted from work at 65 and total years
of college completed, with MI prevalence increased to
53.3% versus 0.0% (19.34, 1.02–365.26). For the men
who did have high cholesterol by 65, but smoked fewer
years by 54 and were non-diabetic at 65, important inter-
actions among factors included having a biological
parent or sibling who had a MI before age 55, the most
he ever weighed in pounds by 72, total household
income at 65 and genotype for the IL6 gene (rs1800795
SNP), with MI prevalence at 32.6% versus 5.3% (8.69,
1.83 to 41.36) (figure 1).
Single factor effects
For men up to 72 years old, the 10 most ‘important’
factors associated with MI determined using RF were as
follows: (1) days/month drinking alcohol, (2) total
household income, (3) dissatisfaction with financial situ-
ation, (4) alcoholic drinks/month, (5) high blood
pressure, (6) number of children, (7) high cholesterol,
(8) the frequency that work required physical effort, (9)
pack-years smoked and (10) worrying a lot, each at
72 years old (see online supplementary figure 1 for add-
itional ‘important’ factors associated with MI by RF).
Of the factors that were associated with MI by RP or
RF, LR identified having high cholesterol by 65 (3.29,
2.59 to 4.18) and 72 (3.32, 2.50 to 4.42), diabetes by 65
(3.24, 2.53 to 4.15) and 72 (2.26, 1.78 to 2.88), stroke by
65 (5.01, 3.36 to 7.48), high blood pressure by 65 (2.39,
1.92 to 2.96) and 72 (2.16, 1.67 to 2.79), exposure to
dangerous conditions at work at 65 (1.41, 1.11 to 1.79)
and having a parent or sibling who had a MI before age
55 (1.89, 1.43 to 2.49) as significantly associated with MI
for men in this study (table 2A). χ2 also identified these
factors as significantly associated with MI.
Overall associations with MI by 72 years of age
Factors identified by at least three of the analyses
employed by this study as associated with MI were com-
piled in order to determine which factors were most
associated with MI in the WLS cohort. For men who had
a MI any time up to 72 years of age, the factors asso-
ciated with MI by all four analyses were having high chol-
esterol by 65, having high cholesterol by 72 and being
diabetic by 65, which were all highly significant by LR
and χ2 (table 2A). These results are supported by the
male RP tree, as having high cholesterol by 65 and
being diabetic by 65 were the first and second nodes in
that tree (figure 1). The factors that were associated
with MI by three of the analyses in this study including
RF were being diabetic by 72, having had a stroke by 65
and having high blood pressure by 72, which were all
highly significant by LR and χ2. The factors that were
associated with MI by three of the analyses including RP
were having high blood pressure by 65, exposure to dan-
gerous conditions at work at 65 and having a parent or
sibling who had a MI before age 55, which were all sig-
nificant by LR and χ2 (table 2A).
MI between 65 and 72 years of age
Interactive effects
In the second set of analyses, 5.9% of men reported a MI
between 65 and 72 years of age. Days/month drinking alco-
holic beverages at 65 years old was the only significant
factor identified as associated with MI among men 65–72
according to RP (figure 2), with incidence at 7.7% among
those who drank<8.5 days/month versus 2.9% among those
who drank ≥8.5 days/month (2.77, 1.80 to 4.25).
Single factor effects
For men between 65 and 72 years of age, the 10 most
‘important’ factors associated with MI determined using
RF were: (1) alcoholic drinks/month at 65 years old, (2)
summary score for distress/depression at 54, (3) body
mass index at 54, (4) alcoholic drinks/month at 54, (5)
summary score for neuroticism at 54, (6) the most ever
weighed (by 65), (7) days/month drinking alcohol at
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65, (8) body mass index at 65, (9) pack-years smoked at
54 and (10) years smoked at 54 (see online
supplementary figure 2 for additional ‘important’
factors associated with MI by RF).
Of the factors that were associated with MI by RP or RF,
LR identified having had a stroke by 65 (4.08, 2.17 to 7.65)
and being diabetic by 65 (2.71, 1.81 to 4.04) as signifi-
cantly associated with MI for men 65–72 years old (table
2B). χ2 also identified these two factors as significantly
associated with MI for men in this age group (table 2B).
Overall associations with MI between 65 and 72 years of age
For men between 65 and 72 years old, the factors asso-
ciated with MI by at least three of the four analyses
employed by this study were having had a stroke by 65
and being diabetic by 65, which were highly significant
by LR and χ2 and ‘important’ factors by RF (table 2B).
Women
MI up to age 72
Interactive effects
RP analysis indicated that 7.5% of women in this study
reported a MI by age 72. For women, being diabetic by
65 was the most significant factor associated with MI
according to RP, with a prevalence of 22.4% versus 4.9%
(5.62, 4.08 to 7.75; figure 3). For the latter group, import-
ant interactions among factors associated with MI
included high blood pressure by 65 and how often they
engaged in light physical activities with others at 67, with
MI prevalence at 3.7% versus 0.2% (18.39, 2.49 to
135.77). And among the women who were non-diabetic,
but did have high blood pressure by 65, important inter-
actions included how many years they had smoked by age
54, with MI prevalence at 16.6% versus 5.1% (3.70, 2.30
to 5.94), and how often the participant blamed them-
selves when they experienced a difficult or stressful event
at 72 years old, with MI prevalence at 11.8% versus 2.7%
(4.87, 2.25 to 10.55; figure 3).
Single-factor effects
For women up to 72 years old, the 10 most ‘important’
factors associated with MI determined using RF were as
follows: (1) days/month drinking alcohol at 72, (2) dis-
satisfaction with financial situation at 72, (3) total house-
hold income at 72, (4) high blood pressure by 72, (5)
worrying a lot at 72, (6) alcoholic drinks/month at 72,
(7) being diabetic by 65, (8) number of children, (9)
Figure 1 RP tree showing interactions among MI-associated factors for men who ever had a MI by 72 years of age in the WLS
cohort, with MI prevalence listed at each node in the tree. MI, myocardial infarction; RP, recursive partitioning; WLS, Wisconsin
Longitudinal Study.
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body mass index at 72 and (10) the most ever weighed
(by 72) (see online supplementary figure 3 for add-
itional ‘important’ factors associated with MI by RF).
Of the factors that were associated with MI by RP or
RF, LR identified being diabetic by 54 (6.93, 4.18 to
11.49), 65 (5.62, 4.08 to 7.75) and 72 (4.24, 3.04
to 5.91), high cholesterol by 72 (2.03, 1.38 to 3.00)
being unmarried at 72 (1.59, 1.16 to 2.18), dissatisfac-
tion with financial situation at 72 ((not at all) 4.00, 1.94
to 8.27; (somewhat) 2.02, 1.31 to 3.12; multiple coeffi-
cients significant by LR), not often engaging in vigorous
physical activity alone at 67 (0.53, 0.32 to 0.89), high
blood pressure at 65 (3.21, 2.34 to 4.39) and 72 (3.37,
2.23 to 5.09) and not often engaging in light physical
activity with others at 67 (0.34, 0.21 to 0.57) as signifi-
cantly associated with MI for women in this study
(table 3A). χ2 also identified these factors as significantly
associated with MI (table 3A).
Overall associations with MI by 72 years of age
For women who reported a MI any time up to 72 years
of age, the factor associated with MI by all four analyses
was being diabetic by 65 years old, which was highly sig-
nificant by LR and χ2 (table 3A), and was the most asso-
ciated factor according to the female RP tree (figure 3).
The factors associated with MI by three of the analyses
in this study including RF were being diabetic by 54 and
72, having high cholesterol by 72, being unmarried at
72, dissatisfaction with financial situation at 72, not often
engaging in vigorous physical activity alone at 67 and
having high blood pressure at 72, which were all signifi-
cant by LR and χ2. The factors associated with MI in
women by three of the analyses in this study including
RP were having high blood pressure by 65 and not often
engaging in light physical activity with others at 67,
which were both highly significant by LR and χ2
(table 3A).
MI between 65 and 72 years of age
Interactive effects
In the second set of analyses, 2.5% of women reported a
MI between 65 and 72 years of age. Being diabetic by
65 years old was again the most significant factor asso-
ciated with MI among women in this age bracket accord-
ing to RP (figure 4), with a MI incidence of 7.8% versus
2.0% (4.25, 2.50 to 7.24). For women who were diabetic
Table 2 MI-associated factors for men found significant by at least three of the four statistical analyses employed by this
study, (A) who ever had an MI by 72 years of age and (B) who had a MI between 65 and 72 years of age.
Factor description
(age at survey year)
MI case/
non-case
(n)
Random forest
‘important’
variables
Logistic
regression
OR (95% CI)
χ2
(adjusted
p value)
Recursive
partitioning
(tree nodes)
(A) Males, ‘MI by 72 years of age’
High cholesterol (by 65 years) 269/893 Yes 3.29 (2.59 to 4.18)*** <0.0001C Present
High cholesterol (by 72 years) 221/987 Yes 3.32 (2.50 to 4.42)*** <0.0001C Present
Diabetes (by 65 years) 124/254 Yes 3.24 (2.53 to 4.15)*** <0.0001C Present
Diabetes (by 72 years) 122/458 Yes 2.26 (1.78 to 2.88)*** <0.0001C
Stroke (by 65 years) 48/56 Yes 5.01 (3.36 to 7.48)*** <0.0001C
High blood pressure (by 72 years) 269/1428 Yes 2.16 (1.67 to 2.79)*** <0.0001C
High blood pressure (by 65 years) 283/1023 2.39 (1.92 to 2.96)*** <0.0001C Present
Exposed to dangerous conditions at
work (by 65 years)
174/784 1.41 (1.11 to 1.79)** 0.0080C Present
Parent or sibling had a MI before age
55 (by 65 years)
82/267 1.89 (1.43 to 2.49)*** <0.0001C Present
(B) Males, ‘MI between 65 and 72 years of age’
Stroke (by 65 years) 13/55 Yes 4.08 (2.17 to 7.65)*** 0.0002F
Diabetes (by 65 years) 36/254 Yes 2.71 (1.81 to 4.04)*** <0.0001C
The ‘age at survey year’ of 65 and 72 represent survey years 2004 and 2011, respectively. Analyses associated with the ‘MI by 72 years of
age’ data set included independent variables from all WLS survey years, 1957–2011, while analyses associated with the ‘MI between 65 and
72 years of age’ data set included only independent variables from WLS survey year 2004 or earlier.
‘***’=p<0.001, ‘**’=p<0.01.
C, χ2 test; F, Fisher’s Exact test.
Figure 2 RP tree showing the only factor associated with MI
by RP for men between 65 and 72 years of age in the WLS
cohort, with MI incidence listed at the terminal nodes of the
tree. MI, myocardial infarction; RP, recursive partitioning;
WLS, Wisconsin Longitudinal Study.
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by 65 years old, important interactions among factors
associated with MI included their summary score for
agreeableness at 65 and not having had a menstrual
period in the last 12 months by 54 years of age, increas-
ing MI incidence to 14.0% versus 0.0% (13.58, 0.79 to
233.29). For those women who were non-diabetic at 65,
important interactions included IQ, genotype for the
INHBB gene SNP (rs11902591) and how often their
work required physical effort at 54, with MI incidence at
25.0% versus 0.0% (37.95, 1.81 to 795.67). And among
those women with a lower IQ score, important interac-
tions included their summary score for extraversion at
54, how often they engaged in light physical activities
alone at 65, the number of alcoholic drinks consumed
per month at 65, body mass index at 65, genotype for
the A2M gene (rs669 SNP), how often they worked
under the pressure of time at 54 and the age at which
they had last menstruated, with MI incidence increasing
to 13.8% versus 0.0% (12.42, 0.72 to 215.47) (figure 4).
Single factor effects
For women between 65 and 72 years of age, the 10 most
‘important’ factors associated with MI determined by RF
were as follows: (1) alcoholic drinks/month at 65 years
old, (2) summary score for distress/depression at 65, (3)
being diabetic by 65, (4) body mass index at 65, (5) the
most ever weighed (by 65), (6) days/month drinking
alcohol at 54, (7) days/month drinking alcohol at 65,
(8) drinks/day on days when drank alcohol at 65, (9)
age when had surgery to remove uterus and/or ovaries
and (10) summary score for distress/depression at 54
(see online supplementary figure 4 for additional
‘important’ factors associated with MI by RF).
Of the factors associated with MI by RP or RF, LR iden-
tified being diabetic by 65 (4.25, 2.50 to 7.24), exposure
to dangerous work conditions at 54 (2.24, 1.36 to 3.69)
and having had a menstrual period in the last 12 months
at 54 (0.46, 0.23–0.91) as significantly associated with MI
for women between 65 and 72 years of age (table 3B). χ2
also identified these factors as significantly associated
with MI for women in this age group (table 3B).
Overall associations with MI between 65 and 72 years of age
For women between 65 and 72 years old, the factor asso-
ciated with MI by all four analyses was being diabetic by
65, which was highly significant by LR and χ2 (table 3B),
and was the factor most associated with MI according to
the female RP tree for this age group (figure 4). The
factors associated with MI by at least three of the ana-
lyses employed in this study were exposure to dangerous
Figure 3 RP tree showing interactions among MI-associated factors for women who ever had a MI by 72 years of age in the
WLS cohort, with MI prevalence listed at each node in the tree. MI, myocardial infarction; RP, recursive partitioning; WLS,
Wisconsin Longitudinal Study.
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Table 3 MI-associated factors for woman found significant by at least three of the four statistical analyses employed by this study, (A) who ever had an MI by 72 years
of age and (B) who had a MI between 65 and 72 years of age.
Factor description (age at survey year)
MI case/
non-case
(n)
Random forest
‘important’
variables
Logistic regression
OR (95% CI)
χ2
(adjusted
p value)
Recursive
partitioning
(tree nodes)
(A) Females, ‘MI by 72 years of age’
Diabetes (by 65 years) 68/236 Yes 5.62 (4.08 to 7.75)*** <0.0001C Present
Diabetes (by 54 years) 24/55 Yes 6.93 (4.18 to 11.49)*** <0.0001C
Diabetes (by 72 years) 64/406 Yes 4.24 (3.04 to 5.91)*** <0.0001C
High cholesterol (by 72 years) 89/1354 Yes 2.03 (1.38 to 3.00)*** 0.0007C
Unmarried (by 72 years) 77/1079 Yes 1.59 (1.16 to 2.18)** 0.0070C
Financial situation – ‘not at all’ satisfied (by 72 years)† 11/73 Yes 4.00 (1.94 to 8.27)*** 0.0002F
Financial situation – ‘somewhat’ satisfied (by 72 years)† 67/879 2.02 (1.31 to 3.12)** 0.0002F
Vigorous physical activity alone 5 years ago - often
(by 72 years)
21/639 Yes 0.53 (0.32 to 0.89)* 0.0330C
High blood pressure (by 72 years) 134/1769 Yes 3.37 (2.23 to 5.09)*** <0.0001C
High blood pressure (by 65 years) 145/1260 3.21 (2.34 to 4.39)*** <0.0001C Present
Light physical activity with others 5 years ago - often
(by 72 years)
23/876 0.34 (0.21 to 0.57)*** 0.0002C Present
(B) Females, ‘MI between 65 and 72 years of age’
Diabetes (by 65 years) 20/236 Yes 4.25 (2.50 to 7.24)*** <0.0001C Present
Exposed to dangerous conditions at work (by 54 years) 28/658 Yes 2.24 (1.36 to 3.69)** 0.0030C
Menstruated in last 12 months (by 54 years) 10/740 0.46 (0.23 to 0.91)* 0.0324C Present
The ‘age at survey year’ of 54, 65 and 72 represent survey years 1993, 2004 and 2011, respectively. Analyses associated with the ‘MI by 72 years of age’ data set included independent
variables from all WLS survey years, 1957–2011, while analyses associated with the ‘MI between 65 and 72 years of age’ data set included only independent variables from WLS survey year
2004 or earlier.
‘***’=p<0.001, ‘**’=p<0.01, ‘*’=p<0.05.
†Multiple coefficients found significant for this variable using logistic regression.
C, χ2 test; F, Fisher’s Exact test.
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work conditions at 54, which was significantly associated
with MI by LR and χ2 and deemed an ‘important’ factor
by RF, and having menstruated in the last 12 months at
54, which was significantly associated by LR and χ2 and
present in the RP tree (table 3B).
SNP associations with MI
None of the genetic variables tested appeared among
the RF ‘important’ factors in any of the groups analysed.
Although this study found several SNPs that were asso-
ciated with MI by RP, specifically the CYP11B2
(rs1799998), the FADS2 (rs174575) and the IL6
(rs1800795) gene SNPs in men up to 72, and the INHBB
(rs11902591) and A2M (rs669) gene SNPs in women
between 65 and 72 years, none of these were signifi-
cantly associated with MI according to LR or χ2 after
adjustment for multiple testing.
Logical bounding
Logical bounding of missing data and subsequent LR
analysis (see the ‘Methods’ section) showed that all
but one of the factors associated with MI identified by
this study were robust to missing data, as they all
remained statistically significant on both sides of the
logical bounding procedure (results not shown). The
only factor that did not remain significant was expos-
ure to dangerous work conditions for women who had
a MI between 65 and 72 years of age, when all missing
data points were coded as ‘yes’, suggesting that this
result was less robust or more sensitive to missing data,
which should be considered when evaluating the
results.
DISCUSSION
This study identified factors associated with MI among
participants in the WLS. For men, the factor most asso-
ciated with reported MI by 72 years old was having had a
stroke by 65. High cholesterol, diabetes, high blood pres-
sure and family history were also identified as top factors
for men up to 72 years, as well as exposure to dangerous
working conditions, which has not previously been iden-
tified as associated with MI in men. Stroke and diabetes
by 65 were most associated with MI in men over
Figure 4 RP tree showing interactions among MI-associated factors for women who had a MI between 65 and 72 years of age
in the WLS cohort, with MI incidence listed at each node in the tree. MI, myocardial infarction; RP, recursive partitioning; WLS,
Wisconsin Longitudinal Study.
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65 years in the WLS cohort. We identified being dia-
betic by 65 as the factor most associated with reported
MI in women up to 72 years old. High cholesterol,
being unmarried, dissatisfaction with finances, not
engaging in physical activity and high blood pressure
were also identified as associated with MI in women up
to 72 years. Among women who had their MI after age
65, being diabetic remained the most associated factor.
However, exposure to dangerous working conditions,
also newly associated with MI in women, and whether
they were still menstruating at 54 were also determined
to be associated with MI for women in this group. For
most of the factors listed, exposure time had a large
effect on MI occurrence, for men and women in the
WLS cohort. Interactions among these and other
factors greatly affected MI occurrence in men and
women. Furthermore, results showed that for men and
women, not only do the MI-associated factors become
less associated as people age, but many of the factors
change or are different between younger and older
people.
Men
MI by 72 years of age
Results showed that 18.1% of men reported a MI to the
WLS by age 72. Stroke by 65 was associated with the
greatest increase in LR odds of MI among these men
(table 2A). The other factors associated with MI in this
group include having high cholesterol, diabetes, high
blood pressure, exposure to dangerous working condi-
tions and having a parent or sibling who had a MI
before age 55. Stroke has been cited as a risk factor for
MI,98 99 and MI has been established as a risk factor for
stroke in prior studies,100–102 and according to the
American Stroke Association103 stroke risk is doubled
among those who have experienced MI due to athero-
sclerosis. Furthermore, high cholesterol, diabetes and
high blood pressure represent three of the four conven-
tional ‘key’ risk factors for MI, and their association with
heart disease and MI risk is well characterised in the lit-
erature.4–6 9 10 104 A family history of heart disease has
been shown to be a significant contributor to MI risk in
previous studies.61 62 105 106 However, our study is the
first to identify a link between exposure to dangerous
working conditions and MI. Consistent with this, a
number of studies show that stress in the workplace is
associated with an increased risk of MI.49 107–109 The
increased odds of MI noted with a diagnosis by 65 years
old rather than 72 (among above factors) suggest that
exposure time is an important determinant in whether
one experiences a MI or not. Although in this particular
cohort having high cholesterol increased one’s odds of
MI by 3.3-fold, regardless of whether it was diagnosed by
65 or 72, prior studies have shown that those who are
diagnosed with high cholesterol at a younger age
(<50 years) are more likely to experience heart disease
in their lifetime.110–112
This study demonstrates that interactions among
factors associated with MI lead to large changes in MI
prevalence (figure 1). While combinations of high chol-
esterol, diabetes, smoking and lower alcohol consump-
tion were associated with increased prevalence and
interacted with lesser-known factors such as depression,
genetic factors, and dangerous working conditions to
increase prevalence up to 50%, other factors including
increased alcohol consumption, higher household
income and higher education tended to lower preva-
lence, in some cases down to 0.0% even when other
top MI risk factors were present. For example, high
cholesterol, smoking and being diabetic are associated
with higher MI prevalence, but for the subset of men
who completed more than 5.5 years of college, preva-
lence in the WLS dropped to 0.0% compared to those
completing <5.5 years of college, whose MI prevalence
was a whopping 53.3%. This suggests that factors
should not be evaluated individually, but rather the
interaction among factors has to be considered when
determining associations with MI (additional discussion
of RP results can be found in online supplementary
information 3).
MI between 65 and 72 years of age
Only 5.9% of men reported a MI between 65 and
72 years to the WLS, versus 18.1% who ever reported MI
by 72 years, therefore the majority of MIs reported by
men to the WLS and included in this study occurred
before age 65. The factors most associated with MI for
men between the ages of 65 and 72 years were having
had a stroke and being diabetic, both by 65 years old
(table 2B). These two factors were identified by both
analyses of MI in men, suggesting that these factors are
strongly associated with MI in men at any age.
Interestingly, the odds of MI in the first analysis for men
who ever had a MI by 72 were increased compared to
the odds of MI between 65 and 72 years old, both for
having had a stroke by 65 (5.0-fold vs 4.1-fold increase,
respectively) and for being diabetic by 65 (3.2-fold vs
2.7-fold increase, respectively), suggesting that the key
risk factors for MI become less predictive as men age, as
supported by previous studies.5 55 Additionally, the loss
of two factors associated with MI in men from the first
analysis, having high cholesterol or having high blood
pressure (table 2B), suggests that factors associated with
MI are different in younger versus older men. This
result is supported by the fact that RP analysis identified
fewer days/month drinking alcoholic beverages at 65 as
the only factor affecting MI among men 65–72 years old,
with a 2.7-fold increase in odds of MI among those who
drank alcohol <8.5 days/month (7.7% vs 2.9%; figure
2). This supports prior studies proposing an insulating
effect of regular moderate alcohol consumption, specif-
ically in older adults (≥65 years),113–115 but still suggests
that the ‘known’ risk factors for MI change with age, at
least for men in the WLS cohort.
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Women
MI by 72 years of age
This study found that 7.5% of women reported MI to
the WLS by age 72, which was 10.6% less than that
reported in men for this age group. LR ORs indicated
that being diabetic by 54 was associated with the greatest
increase in odds of MI (table 3A). The other factors
associated with MI for women in this group include
being diabetic (any age), having high cholesterol, being
unmarried, dissatisfaction with financial situation, not
engaging in physical activity and having high blood pres-
sure. Being diabetic (by 65) was also the single most
important factor for MI among women up to 72 accord-
ing to RP results (figure 3), with a 4.6-fold increase in
MI prevalence among diabetic women (22.4% vs 4.9%).
Diabetes has been shown in prior studies to be a strong
predictor of MI risk in women.116 As seen in men in this
study, high cholesterol and high blood pressure are
strongly associated with MI risk in women, as supported
by previous studies. Marriage is a well-accepted indicator
of MI risk and an even better indicator of one’s recovery
and health after experiencing an MI.117–122
Dissatisfaction with one’s financial situation was linked
with MI risk in women in one prior study,123 and
another study showed an association between ‘perceived
financial status’ and MI risk among employed women.124
Dissatisfaction with one’s financial situation could also
be associated with financial stress, which has been linked
to increased MI risk in multiple studies.49 55 125 Reduced
prevalence of MI in women in the WLS cohort who
engaged in physical activity when they were about
67 years old is supported by numerous studies on the
effects of physical inactivity and MI risk.3 5 40 55 An even
larger reduction in MI prevalence was noted among
those who often engaged in light physical activity with
others when 67 (0.34) versus those who often engaged
in vigorous physical activity alone when 67 (0.53), sug-
gesting that type of physical activity is less important and
spending time with others may play a larger role for
women when it comes to reducing MI risk. This is sup-
ported by previous studies showing that for women
having ‘social support’ decreases risk of MI.126 127
Furthermore, our study suggests that physical inactivity
may play a more important role for women than for
men when it comes to MI (table 3A), specifically con-
cerning MI in those <65 years old, as supported by previ-
ous studies.55
In addition to identifying being diabetic by 65 as the
most associated factor for women up to 72 years in the
WLS cohort (figure 3), RP analysis showed that among
those women who were non-diabetic at 65, the inter-
action of having high blood pressure by 65 and smoking
≥24.5 years by 54 more than tripled MI prevalence,
again demonstrating the importance of considering
interactions among factors when predicting MI risk
(additional discussion of RP results can be found in
online supplementary information 4). As in men, our
study suggests that exposure time to certain factors is an
important determinant in whether a woman has a MI or
not. For example, odds of MI increase for diabetic
women, but the younger a woman is when she is diag-
nosed, the higher her odds for eventually experiencing
a MI, with a 6.9-fold, 5.6-fold and 4.2-fold increase in
odds among those diagnosed by 54, 65 and 72 years old,
respectively (R2=0.98). However, this association does
not hold for all medical health conditions in women in
the WLS. For example, high blood pressure by 54 was
not associated with MI, but was associated with increased
odds of MI at 65 years (3.2-fold), and this increase in
odds remained stable at 72 years (3.4-fold). Further
study will need to be conducted in order to determine
the exact mechanisms by which exposure time affects
one’s odds of having a MI and which MI-associated
factors are more susceptible to this effect.
MI between 65 and 72 years of age
Only 2.5% of women reported a MI between 65 and
72 years to the WLS—much lower than that noted
among women who ever reported a MI by 72 years old
(7.5%). The factor associated with the highest odds of
MI for women in this age group was being diabetic by
65 years old (table 3B), similar to women who ever had
a MI by 72 years. RP analysis confirmed diabetes as the
top factor associated with MI among women 65 to
72 years old (figure 4), again suggesting that this is
potentially the most important factor associated with MI
in women. However, just as in men, this factor is more
associated with MI among younger women, or including
those <65 years old, with a 5.62-fold increase as com-
pared to the 4.25-fold increase in odds among those
who experienced a MI after 65 years old (table 3B).
Even so, this remained the most important factor asso-
ciated with MI among women in the WLS at any age.
This result is in agreement with what is known about dia-
betes and MI risk for women, as it has been shown that
being diabetic increases not only a woman’s MI risk, but
also her risk for fatal coronary heart disease, ischaemic
stroke, cardiovascular mortality and all-cause mortal-
ity.116 128–130
Additionally and interestingly, exposure to dangerous
conditions at work (at 54 years old) was determined to
be associated with MI for women 65–72 years old
(2.2-fold increase; table 3B), just as exposure to danger-
ous work conditions (at 65 years) was a top factor for
men who ever had a MI by 72 years (1.4-fold increase;
table 2A). This may represent a possible new risk factor
for MI, although more research is needed to confirm
this result. Still it suggests that not only do MI-associated
factors become less associated as women age, but those
factors may change between younger and older women.
This is supported by the last MI-associated factor for
women 65–72 years old, whether she still had her men-
strual period at 54 (0.46-fold decrease in odds; table 3B).
The age at which a woman experiences her last men-
strual cycle affects the age at which large, lasting hormo-
nal changes take place in her body and has a very large
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impact on her ageing and overall health. Supporting the
results of this study, it has been shown that the earlier a
woman stops menstruating, the shorter her lifespan and
the more health problems she will encounter in later
years, including an increased risk of MI.131–141 Indeed,
we have previously demonstrated in the WLS that the
earlier a woman stops menstruating, the shorter her life-
span will be (Yonker et al., 2013). Our results are further
supported by studies showing that hormone replacement
therapy can ameliorate the effects of natural or surgical
menopause, specifically in younger women.142 144 In
other words, the longer a woman’s hypothalamic-pituit-
ary-gonadal axis remains in balance, the lower her odds
of experiencing a MI later in life (between 65 and
72 years old). The ‘exposure to dangerous conditions at
work’ factor was shown to be more sensitive to missing
data points in our logical bounding procedure, there-
fore additional work is needed to follow-up on this
finding. However, this same factor was identified in men
and women in this study, lending support to our result.
Among those women 65–72 years old in the ‘riskiest’
group, those who were diabetic by 65, the interaction of
being less agreeable and having stopped menstruating by
54 resulted in a doubling of MI incidence, while those
who were more agreeable or who did still menstruate
when they were 54 experienced no MI, despite having
the top MI-associated factor for women (figure 4).
Among women who were non-diabetic at 65, the inter-
action of three other identified factors was associated
with an increased MI incidence to 25%—3.2 times higher
incidence than that noted before the interaction (see the
‘Results’ section). These examples highlight the import-
ance of interactions among factors when predicting one’s
MI risk (figure 4; additional discussion of RP results can
be found in online supplementary information 5).
SNP associations with MI
Although this study found several SNPs that were asso-
ciated with MI by RP, none of these were significantly
associated with MI according to LR or χ2 after adjustment
for multiple testing. Interestingly, while some studies have
found an association of CYP11B2 (rs1799998) and IL6
(rs1800795) with cardiovascular disease or MI,145–152
other studies have not found an association.153–156 Future
genome-wide association studies will provide more defin-
ite data as to the role these SNPs play in the disease.
Limitations
Few studies have included the breadth of factors evalu-
ated in the present study; however, despite high partici-
pant response rates to the WLS, our largest limitation
was the loss of WLS participants due to the design of the
two dependent variables, attrition from the WLS and
missing data common to survey studies (see online
supplementary table S1). If the population of partici-
pants excluded from the study was somehow different
from the population included, it may have created a bias
which could affect our results. However, as stated above,
missing data is a limitation in every observational study
and is an unavoidable consequence of using longitu-
dinal survey data. Furthermore, the logical bounding
procedure we performed showed that all but one of the
‘overall’ MI-associated factors identified were robust to
missing data, lending support to our results.
An additional limitation in this study is that it is likely
that some reported MIs may have occurred before some of
the independent variables were measured, specifically for
the ‘MI by 72 years of age’ analyses. Our data set did not
include the dates of occurrence of all independent vari-
ables, therefore it was impossible to run a ‘time-to-event’
or survival analysis on these data. However, we were inter-
ested in factors present in participants who ever experi-
enced a MI in their lifetime (up to 72 years), regardless of
when their MI occurred. Therefore, this part of our ana-
lysis is a case–control retrospective study. Owing to the
mentioned complications with the first analysis, we com-
pleted a second analysis in which all of the independent
variables occurred before the participant’s reported MI.
Although this design reduced the number of participants
included in the second analysis, it allowed us to determine
which factors are associated with MI before the MI occurs
and therefore are potentially predictive of MI. This part of
our analysis is a true cohort study.
Additional limitations of the current study include lim-
itations associated with ICD codes in death records and
limitations in death records recovered by the WLS.
Furthermore, Rosamond et al157 found that when MI are
self-reported, the numbers are often an overestimation.
Again, these limitations are an unavoidable consequence
of using longitudinal survey data, but still must be
considered when interpreting results. Additionally, the
predictive value of our genetic data was limited because
of user bias in selection of SNPs; other genetic
variants that we did not examine in this study may have
provided information about crucial interactions involved
with MI. Furthermore, the WLS has social-factor
homogeneities, such as participants being almost exclu-
sively non-Hispanic white people with middle-class to
upper-middle-class backgrounds. Future directions for
research will involve using these same machine-learning
methodologies on more complete genetic profiles, such
as from genome-wide SNP or sequencing data, with
which we will be able to explore all genetic interaction
possibilities rather than a limited subset of variants.
CONCLUSIONS
It has previously been shown that at least one of four key
risk factors—smoking, high blood pressure, high choles-
terol or diabetes (mellitus)—was observed in more than
80–90% of patients experiencing MI, and all of these
risks combined account for a population attributable
risk >90% for all MI—for men and women, old and
young, worldwide.5 55 However, our study indicated that:
(1) the main factors associated with MI are different
between men (high cholesterol, diabetes, stroke, high
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blood pressure and family history) and women (dia-
betes, high cholesterol, being unmarried, dissatisfaction
with financial situation, physical inactivity, high blood
pressure and loss of menstruation); (2) interactions
among MI-associated factors have a large influence on
MI occurrence; (3) factors associated with MI change
and associations weaken after 65 years of age in both
sexes and (4) the interaction of factors can be associated
with large reductions in MI prevalence, to near zero,
even in the presence of one or more of the 4 key risk
factors for MI. In addition to identifying the above
recognised factors associated with MI, we found one pre-
viously unidentified factor associated with MI (exposure
to dangerous conditions at work) among WLS partici-
pants, which may represent a ‘new’ risk factor for MI.
Larger genetic studies are required to elaborate on the
modest genetic interactions identified in this study.
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